Please assess the completion status of the following clinical trial:

Trial Title: Phase 1 and Phase 2 Clinical Trials of SNUBH-NM-333(18F)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy young controls who are 20 - 30 years old and have no subjective memrory complaints~* Cognitively normal elderly who have Clinical Dementia Rating score of 0~* Alzheimer's disease (AD) patients who met both the DSM-IV criteria for dementia and NINCDS-ADRDA criteria for probable AD~Exclusion Criteria:~* any present serious medical, psychiatric, or neurological disorder that could affect mental function; evidence of focal brain lesions on MRI; the presence of severe behavioral or communication problems

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 80 Years
- Healthy Volunteers: t

Study Arms:
- SNUBH-NM-333(18F), Safety, Efficacy (Type: EXPERIMENTAL): 10 young controls, 10 cognitively normal elderly, and 10 Alzheimer's disease patients

Based on this trial design, predict the completion outcome and termination type (if applicable).